Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...

Marley Mansour was diagnosed in early 2023 after years of unanswered questions. The rare genetic disorder affects protein ...

Scientists can now design genetic material called mRNA to help us build immunity to certain viruses, including SARS-CoV-2, ...

Because of misunderstanding about mRNA technology, there is a move, through legislation, to limit the use of it in several states, including right here in Texas.

Yeast Yra1 and its metazoan orthologues bind mRNAs and interact with multiple mRNA export factors.Transport of proteins and small RNAs does not require Yra1 or any other proteins required for mRNA ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and rollout of COVID-19 vaccines. The funds from the ...

Moderna (NasdaqGS:MRNA) recently reported a decline in revenue for Q1 2025, but managed to reduce its net loss and improve its loss per share. Despite this, the company's stock price was ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

In recent years, the development of sophisticated methodologies based on second- and third-generation sequencing has enabled the RNA community to explore ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...